Article Versions Notes

Miyazaki M, Yanagida R, Nakashima A, Matsuo K, Moriwaki N, Uchiyama M, Yamada Y, Hirata H, Kushima H, Kinoshita Y, et al. Evaluation of Remdesivir for Mildly to Moderately Ill Patients with COVID-19: A Single-Arm, Single-Center, Retrospective Study. Medicina. 2022; 58(8):1007. https://doi.org/10.3390/medicina58081007

Miyazaki, Motoyasu, Ryoko Yanagida, Akio Nakashima, Koichi Matsuo, Norihiro Moriwaki, Masanobu Uchiyama, Yota Yamada, Hitomi Hirata, Hisako Kushima, Yoshiaki Kinoshita, and et al. 2022. "Evaluation of Remdesivir for Mildly to Moderately Ill Patients with COVID-19: A Single-Arm, Single-Center, Retrospective Study" Medicina 58, no. 8: 1007. https://doi.org/10.3390/medicina58081007

Miyazaki, M., Yanagida, R., Nakashima, A., Matsuo, K., Moriwaki, N., Uchiyama, M., Yamada, Y., Hirata, H., Kushima, H., Kinoshita, Y., Ishii, H., & Imakyure, O. (2022). Evaluation of Remdesivir for Mildly to Moderately Ill Patients with COVID-19: A Single-Arm, Single-Center, Retrospective Study. Medicina, 58(8), 1007. https://doi.org/10.3390/medicina58081007